Understanding the EORTC QLQ-BM22, the module for patients with bone metastases-Reference-Cited by-同舟云学术

Understanding the EORTC QLQ-BM22, the module for patients with bone metastases

Published:2009-10 Issue:5 Volume:9 Page:461-465
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Chow Edward,Bottomley Andrew

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1586/erp.09.50

Reference8 articles.

1. Incidence, prevalence and distribution of bone metastases

2. The management of acetabular insufficiency secondary to metastatic malignant disease.

3. Harrington KD. Prophylactic management of impending fractures. In:Orthopedic Management of Metastatic Bone Disease.Harrington KD (Ed.). CV Mosby, St Louis, MO, USA, 283–307 (1988).

4. The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical results and quality of life after single-stage posterior transpedicular approach for circumferential epidural decompression in patients with thoracolumbar spine metastasis;Journal of Cancer;2023

2. Pain control with palliative radiotherapy in patients with bone metastases;Bone Cancer;2022

3. “The use of bisphosphonates to treat skeletal complications in solid tumours”;Bone;2021-06

4. Impact of the COVID-19 pandemic on quality of life and emotional wellbeing in patients with bone metastases treated with radiotherapy: a prospective cohort study;Clinical & Experimental Metastasis;2021-02-25

5. Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents– a real-world cross-sectional study from Switzerland (SAKK 95/16);BMC Cancer;2021-02-19